Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia

被引:7
|
作者
Zhang, Xin-Yue [1 ,2 ]
Dai, Hai-Ping [1 ,2 ]
Li, Zheng [1 ,2 ]
Yin, Jia [1 ,2 ]
Lang, Xing-Ping [3 ]
Yang, Chun-Xiao [3 ]
Xiao, Sheng [4 ]
Zhu, Ming-Qing [1 ,2 ]
Liu, Dan-Dan [1 ,2 ]
Liu, Hong [1 ,2 ]
Shen, Hong-Jie [1 ,2 ]
Wu, De-Pei [1 ,2 ]
Tang, Xiao-Wen [1 ,2 ]
机构
[1] Soochow Univ, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[3] Sano Suzhou Precis Med Co Ltd, Suzhou, Peoples R China
[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
来源
FRONTIERS IN ONCOLOGY | 2021年 / 10卷
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
fusion gene; STRBP-JAK2; Ph-like; chimeric antigen receptor; B-lymphoblastic leukemia; BINDING PROTEIN; KINASE; STRATEGIES;
D O I
10.3389/fonc.2020.611467
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Philadelphia chromosome-like B-lymphoblastic leukemia (Ph-like ALL) describes a group of genetically heterogeneous, Ph-negative entities with high relapse rates and poor prognoses. A Janus-kinase-2 (JAK2) rearrangement has been reported in approximately 7% of Ph-like ALL patients whose therapeutic responses to JAK inhibitors have been studied in clinical trials. Here, we report a novel STRBP-JAK2 fusion gene in a 21-year-old woman with Ph-like ALL. Although a normal karyotype was observed, a hitherto unreported JAK2 rearrangement was detected cytogenetically. STRBP-JAK2 fusion was identified by RNA sequencing and validated by Sanger sequencing. The Ph-like ALL proved refractory to traditional induction chemotherapy combined with ruxolitinib. The patient consented to infusion of autologous chimeric antigen receptor (CAR) T cells against both CD19 and CD22, which induced morphologic remission. Haplo-identical stem cell transplantation was then performed; however, she suffered relapse at just one month after transplantation. The patient subsequently received donor lymphocyte infusion after which she achieved and maintained a minimal residual disease negative remission. However, she succumbed to grade IV graft-versus-host disease 7 months post-transplant. In conclusion, this report describes a novel STRBP-JAK2 gene fusion in a Ph-like ALL patient with a very aggressive disease course, which proved resistant to chemotherapy combined with ruxolitinib but sensitive to immunotherapy. Our study suggests that CAR T-cell therapy may be a viable option for this type of leukemia.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Novel Fusion of TCF3-MEF2B in BCR-ABL Negative B-Lymphoblastic Leukemia
    Cloe, Adam
    Pillai, Raju
    Telatar, Milhan
    Yew, Hooi
    Weisenburger, Dennis D.
    Pullarkat, Vinod
    Aldoss, Ibrahim
    Kuo, Ching-Ying
    Aoun, Patricia
    Afkhami, Michelle
    LABORATORY INVESTIGATION, 2018, 98 : 508 - 509
  • [42] Characterization of a cryptic KMT2A/AFF1 gene fusion by mate-pair sequencing (MPseq) in a young adult with newly diagnosed B-lymphoblastic leukemia
    Peterson, Jess F.
    Smoley, Stephanie A.
    Luoma, Ivy M.
    Pitel, Beth A.
    Rice, Christopher S.
    Demasi, Jonna C. Benevides
    Vasmatzis, George
    Smadbeck, James B.
    Yang, Tong
    Greipp, Patricia T.
    Ketterling, Rhett P.
    Baughn, Linda B.
    JOURNAL OF HEMATOPATHOLOGY, 2019, 12 (02) : 99 - 104
  • [43] Novel Fusion of TCF3-MEF2B in BCR-ABL Negative B-Lymphoblastic Leukemia
    Cloe, Adam
    Pillai, Raju
    Telatar, Milhan
    Yew, Hooi
    Weisenburger, Dennis D.
    Pullarkat, Vinod
    Aldoss, Ibrahim
    Kuo, Ching-Ying
    Aoun, Patricia
    Afkhami, Michelle
    MODERN PATHOLOGY, 2018, 31 : 508 - 509
  • [44] Characterization of a cryptic KMT2A/AFF1 gene fusion by mate-pair sequencing (MPseq) in a young adult with newly diagnosed B-lymphoblastic leukemia
    Jess F. Peterson
    Stephanie A. Smoley
    Ivy M. Luoma
    Beth A. Pitel
    Christopher S. Rice
    Jonna C. Benevides Demasi
    George Vasmatzis
    James B. Smadbeck
    Tong Yang
    Patricia T. Greipp
    Rhett P. Ketterling
    Linda B. Baughn
    Journal of Hematopathology, 2019, 12 : 99 - 104
  • [45] PRECLINICAL EFFICACY OF A NOVEL KINASE INHIBITOR FOR THE TREATMENT OF THE PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH JAK2 GENE REARRANGEMENTS
    Quadri, M.
    Saitta, C.
    Rigamonti, S.
    Grioni, A.
    Palmi, C.
    Biondi, A.
    Cazzaniga, G.
    Fazio, G.
    HAEMATOLOGICA, 2020, 105 : S50 - S50
  • [46] Targeting JAK2 Gene Rearrangements with a Novel Kinase Inhibitor in a Preclinical Model of Pediatric Acute Lymphoblastic Leukemia
    Quadri, Manuel
    Saitta, Claudia
    Palamini, Sonia
    Palmi, Chiara
    Biondi, Andrea
    Cazzaniga, Giovanni
    Fazio, Grazia
    BLOOD, 2021, 138
  • [47] Sustained remission after ruxolitinib and chimeric antigen receptor T-cell therapy bridged to a second allogeneic hematopoietic stem cell transplantation for relapsed Philadelphia chromosome-like B-cell precursor acute lymphoblastic leukemia with novel NPHP3-JAK2 fusion
    Chen, Xue
    Yuan, Lili
    Zhou, Jiarui
    Wang, Fang
    Zhang, Yang
    Ma, Xiaoli
    Cao, Panxiang
    Fang, Jiancheng
    Chen, Jiaqi
    Zhou, Xiaosu
    Wu, Qisheng
    Liu, Ming
    Liu, Hongxing
    GENES CHROMOSOMES & CANCER, 2022, 61 (01): : 55 - 58
  • [48] Concurrent EPOR::IGH fusion gene and numerous cytoplasmic granules in BCR::ABL1-like B-lymphoblastic leukemia
    Long, Fang
    Bai, Mingming
    Zheng, Fan
    Li, Ting
    Zhang, Xiaohui
    PEDIATRIC BLOOD & CANCER, 2024, 71 (04)
  • [49] Identification of a novel TOP2B::AFF2 fusion gene in B-cell acute lymphoblastic leukemia
    Liu, Tao
    Wang, Yang
    An, Xi-Zhou
    Liu, Jiaqi
    Wu, Yuqin
    Xiang, Yan
    Zhang, Yong-Jie
    Huang, Lan
    Li, Jia-Cheng
    Li, Yu-Zhuo-Pu
    Yu, Jie
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [50] A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia
    Mohamed, Sara M. A.
    Wohlmann, Andreas
    Schofield, Peter
    Sia, Keith C. S.
    McCalmont, Hannah
    Savvides, Savvas N.
    Verstraete, Kenneth
    Kavallaris, Maria
    Christ, Daniel
    Friedrich, Karl-Heinz
    Bayat, Narges
    Lock, Richard B.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 190 : 214 - 223